Asprosin in Behect Patients
ConditionBehcet Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University
About this trial
This study aims to investigate serum Asprosin concentrations in patients with BD and their relationship with disease activity and major clinical manifestations.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adult subjects (≥ 18 years) satisfying the International Criteria for Behçet's Disease (ICBD) will be included in [7].
Disqualifiers
Patients with other autoimmune diseases.
Patients with Acute inflammatory condition at the time of blood sampling.
Pregnant participants, and participants with active infection, known malignancy, diabetes mellitus, chronic kidney or liver disease, thyroid or other endocrine disorders, obesity.
Trial population
The study will include adult patients with Behçet's disease fulfilling the International Criteria for Behçet's Disease (ICBD), as well as age- and sex-matched healthy controls. Patients will be recruited from the Rheumatology Department. The study will assess serum Asprosin levels in relation to disease activity in Behçet's disease.
Trial design
Design model
Case-control
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Assessment of asprosin level in behcet disease and its association with disease activity
To investigate serum asprosin level in behcet disease
Time frame
Baseline2
Assessment of asprosin level in behcet disease and its association with disease activity
To investigate serum Asprosin concentrations in patients with BD.
Time frame
Baseline assessment at the time of enrollmentLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: